57f33dc4_id_reviews__first_test_results__Cochrane_conclusion
[Our score] -0.37 [Our narrative conclusion] likely to be ineffective [Agree?] Y [Cochrane conclusion] 
Omega-3 fatty acids appear to have little haematological benefit in people with intermittent claudication and there is no evidence of consistently improved clinical outcomes (quality of life, walking distance, ankle brachial pressure index or angiographic findings). Supplementation may also cause adverse effects such as nausea, diarrhoea and flatulence. Further research is needed to evaluate fully short- and long-term effects of omega-3 fatty acids on the most clinically relevant outcomes in people with intermittent claudication before they can be recommended for routine use.
Liberating the literature: Ultra-rapid reviews, first test results
Cochrane conclusion